Abstract

The tetrasaccharide hapten released from the glycopeptidolipid (GPL) antigen of Mycobacterium avium serovar 20 has been characterized as O-(2-O-methyl-α-d-rhamnopyranosyl)-(1 → 3)-O-(2-O-methyl-α-l-fucopyranosyl)-(1 → 3)-α-l-rhamnopyranosyl-(1 → 2)-6-deoxy-l-talose. Syntheses are reported of allyl glycosides of the outer disaccharide unit of this hapten, O-(2-O-methyl-α-d-rhamnopyranosyl)-(1 → 3)-2-O-methyl-α-l-fucopyranose, and also of the outer di- and tri-saccharide units of the GPL antigen of M. avium serovar 14, O-(N-formyl-α-l-kansosaminyl)-(1 → 3)-2-O-methyl-α-d-rhamnopyranose and O-(N-formyl-α-l-kansosaminyl)-(1 → 3)-O-(2-O-methyl-α-d-rhamnopyranosyl-(1 → 3)-2-O-methyl-α-l-fucopyranose. The key steps in the latter synthesis involve the preparation of allyl 4-azido-4,6-dideoxy-3-C-methyl-2-O-methyl-α-l-mannopyranoside as a precursor for the N-formylkansosamine unit, followed sequentially by conversion into and use of a trichloroacetimidate as glycosyl donor for di- and tri-saccharide formation, O-deacylation, reduction, and N-formylation. The allyl glycosides, representative of the haptens from both serovars, have been converted into neoglycoproteins (NGPs) and their serological activities have been compared in the light of the structural relationship between them.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.